Rekombinanter IL2RA (Daclizumab Biosimilar) Antikörper

Produktnummer ABIN7487732

Dieses Maus Chimeric-Antikörper erkennt spezifisch IL2RA (Daclizumab Biosimilar) in FACS und BR. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für Rekombinanter IL2RA (Daclizumab Biosimilar) Antikörper (ABIN7487732)

Target: IL2RA (Daclizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Chimeric

Konjugat: Dieser IL2RA (Daclizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Blocking Reagent (BR)

Produktdetails anti-IL2RA (Daclizumab Biosimilar) Antikörper

Verwendungszweck: Anti-IL-2R [Daclizumab], Mouse IgG1, kappa

Spezifität: Binds to p55 chain of IL2R on human T cells, Tac antigen, which is expressed on T cells activated by mitogens, soluble antigens, and alloantigens but not on resting T cells, thymocytes, B cells, monocytes, activated B cells, leukemic T cell blasts from patients with acute lymphoblastic leukemia, and long-term T cell lines.

Kreuzreaktivität: Cynomolgus, Rhesusaffen

Produktmerkmale:

Original Species of Ab: Human

Original Format of Ab: IgG1

Aufreinigung: Protein A affinity purified

Immunogen: Cultured T-cells derived from a patient with Mycosis fungoides.

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu IL2RA (Daclizumab Biosimilar)

Target: IL2RA (Daclizumab Biosimilar)

Hintergrund: CD25, Interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2R subunit alpha, IL-2-RA, IL2-RA, TAC antigen, p55

UniProt: P01589